(Post-pandemic Era)-Global Brucellosis Vaccines Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
- Report Code : XYZ2438692
- Published On: Apr, 2021
- Category : Medical Devices
- Pages : 110
-
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Research published a report for global Brucellosis Vaccines market in this environment.
In terms of revenue, this research report indicated that the global Brucellosis Vaccines market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Brucellosis Vaccines industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Jinyu aims at producing XX K Units Brucellosis Vaccines in 2020, with XX % production to take place in global market, Colorado Serum accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Brucellosis Vaccines Market Include by
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Brucellosis Vaccines Market
Jinyu
Colorado Serum
Boehringer Ingelheim
Biogenesis-Bago
Vetal Company
CZ Veterinaria
SYVA Laboratorios
Indian Immunologicals
Qilu
Tecnovax
Hester Biosciences
Zoetis
Onderstepoort Biological
Instituto Rosenbusch
Ceva Sante Animale
Calier & Biologicos Laverlam
Biovet
Major Type of Brucellosis Vaccines Covered in Research report:
S19 Vaccine
RB51 Vaccine Strain
Other
Application Segments Covered in Research Market
Cattle
Sheep
Other
For any other requirements, please feel free to contact us and we will provide you customized report.
-
With tables and figures helping analyze worldwide (Post pandemic Era) Global Brucellosis Vaccines market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Global Brucellosis Vaccines Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope1.1 Product Details and Introduction
1.1.1 S19 Vaccine -Product Introduction and Major Manufacturers
1.1.2 RB51 Vaccine Strain -Product Introduction and Major Manufacturers
1.1.3 Other -Product Introduction and Major Manufacturers1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Brucellosis Vaccines Market Assessment, by Segmentation2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis3.1 China Brucellosis Vaccines Market
3.1.1 Top Companies leading Brucellosis Vaccines Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Brucellosis Vaccines Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)3.2 EU Brucellosis Vaccines Market
3.2.1 Top Companies leading Brucellosis Vaccines Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Brucellosis Vaccines Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)3.3 USA Brucellosis Vaccines Market
3.3.1 Top Companies leading Brucellosis Vaccines Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Brucellosis Vaccines Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)3.4 Japan Brucellosis Vaccines Market
3.4.1 Top Companies leading Brucellosis Vaccines Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Brucellosis Vaccines Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)3.5 India Brucellosis Vaccines Market
3.5.1 Top Companies leading Brucellosis Vaccines Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Brucellosis Vaccines Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)3.6 Southeast Asia Brucellosis Vaccines Market
3.6.1 Top Companies leading Brucellosis Vaccines Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Brucellosis Vaccines Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Brucellosis Vaccines Market
3.7.1 Top Companies leading Brucellosis Vaccines Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Brucellosis Vaccines Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)4.1 Brucellosis Vaccines Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream4.2 COVID-19 Impact on Brucellosis Vaccines Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)5.1 Global Brucellosis Vaccines Sales and Growth Rate (2021-2027)
5.2 Global Brucellosis Vaccines Sales Value and Growth Rate (2021-2027)
6 Brucellosis Vaccines Competitive Analysis6.1 Jinyu
6.1.1 Jinyu Company Profiles
6.1.2 Jinyu Product Introduction
6.1.3 Jinyu Brucellosis Vaccines Production, Revenue (2016-2021)
6.1.4 SWOT Analysis6.2 Colorado Serum
6.2.1 Colorado Serum Company Profiles
6.2.2 Colorado Serum Product Introduction
6.2.3 Colorado Serum Brucellosis Vaccines Production, Revenue (2016-2021)
6.2.4 SWOT Analysis6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Profiles
6.3.2 Boehringer Ingelheim Product Introduction
6.3.3 Boehringer Ingelheim Brucellosis Vaccines Production, Revenue (2016-2021)
6.3.4 SWOT Analysis6.4 Biogenesis-Bago
6.4.1 Biogenesis-Bago Company Profiles
6.4.2 Biogenesis-Bago Product Introduction
6.4.3 Biogenesis-Bago Brucellosis Vaccines Production, Revenue (2016-2021)
6.4.4 SWOT Analysis6.5 Vetal Company
6.5.1 Vetal Company Company Profiles
6.5.2 Vetal Company Product Introduction
6.5.3 Vetal Company Brucellosis Vaccines Production, Revenue (2016-2021)
6.5.4 SWOT Analysis6.6 CZ Veterinaria
6.6.1 CZ Veterinaria Company Profiles
6.6.2 CZ Veterinaria Product Introduction
6.6.3 CZ Veterinaria Brucellosis Vaccines Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 SYVA Laboratorios
6.7.1 SYVA Laboratorios Company Profiles
6.7.2 SYVA Laboratorios Product Introduction
6.7.3 SYVA Laboratorios Brucellosis Vaccines Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Indian Immunologicals
6.8.1 Indian Immunologicals Company Profiles
6.8.2 Indian Immunologicals Product Introduction
6.8.3 Indian Immunologicals Brucellosis Vaccines Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 Qilu
6.9.1 Qilu Company Profiles
6.9.2 Qilu Product Introduction
6.9.3 Qilu Brucellosis Vaccines Production, Revenue (2016-2021)
6.9.4 SWOT Analysis6.10 Tecnovax
6.10.1 Tecnovax Company Profiles
6.10.2 Tecnovax Product Introduction
6.10.3 Tecnovax Brucellosis Vaccines Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
6.11 Hester Biosciences
6.12 Zoetis
6.13 Onderstepoort Biological
6.14 Instituto Rosenbusch
6.15 Ceva Sante Animale
6.16 Calier & Biologicos Laverlam
6.17 Biovet
7 Conclusion
-
The (Post pandemic Era) Global Brucellosis Vaccines Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
New players are entering the (Post pandemic Era) Global Brucellosis Vaccines Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.
Depending upon the type of applications, the (Post pandemic Era) Global Brucellosis Vaccines Market has been segmented into
According to the report, the (Post pandemic Era) Global Brucellosis Vaccines Industry will grow to USD XXX Million by 2029, with a YY% CAGR.
In addition to the (Post pandemic Era) Global Brucellosis Vaccines Market share analysis by competitors, the report also includes chapters on the HHI Index, CR4, and CR8 to characterize the concentration rate and competitive character of the (Post pandemic Era) Global Brucellosis Vaccines Market.
The latest version of the (Post pandemic Era) Global Brucellosis Vaccines Market study includes a market size breakdown by relevant business segments, applications, and geography, as well as qualitative insights such as Patent Analysis*, Market Entropy, Key Development Activities, Market Dynamics, PEST and PORTER models, and more.
